President Donald J. Trump has once again shaken up the healthcare industry—this time by making weight loss more affordable for millions of Americans. In a stunning announcement, Trump revealed a landmark agreement with pharmaceutical giants Eli Lilly and Novo Nordisk that will drastically reduce the cost of popular weight-loss drugs Wegovy and Zepbound.

Under the new “Most Favored Nation” pricing plan, Wegovy will drop from an astonishing $1,350 per month to just $250, while Zepbound will fall from $1,080 to $346. Reports suggest that under the finalized agreement, select Americans could soon pay as little as $150 a month for these life-changing medications.

This move marks a defining moment in Trump’s ongoing effort to make healthcare accessible and affordable without compromising innovation or quality. By leveraging the full strength of American negotiating power, the Trump Administration is directly confronting Big Pharma’s decades-long monopoly on pricing. Supporters hail this as another example of Trump’s “America First” economic policy in action—putting the interests of ordinary citizens before corporate profit.

For millions struggling with obesity and metabolic health issues, this decision could represent more than savings—it could mean a path to longer, healthier lives. Experts predict this initiative will also spark competitive reform across the pharmaceutical industry, forcing other companies to follow suit or risk losing their U.S. market share.

In a statement, Trump reaffirmed his commitment to lowering healthcare costs for all Americans: “We’re making being healthy affordable again. Nobody thought it could be done—but we did it. We’re putting people first, not the drug companies.”

Critics who once doubted the administration’s ability to take on pharmaceutical giants are now left to acknowledge a simple fact: Trump’s direct, results-driven approach continues to produce measurable wins for American families. Whether it’s job creation, energy independence, or healthcare reform, Trump’s focus remains unchanged—building a stronger, healthier America.